000867240 000__ 03446cam\a2200397\i\4500
000867240 001__ 867240
000867240 005__ 20210515163050.0
000867240 008__ 181024t20192019nyu\\\\\\b\\\\001\0\eng\\
000867240 010__ $$a  2018048368
000867240 019__ $$a1089732490$$a1101645875
000867240 020__ $$a9780062338785$$q(hardcover)
000867240 020__ $$a0062338781$$q(hardcover)
000867240 020__ $$a9780062338792
000867240 020__ $$a006233879X
000867240 035__ $$a(OCoLC)on1057377213
000867240 035__ $$a867240
000867240 040__ $$aDLC$$beng$$erda$$cDLC$$dOCLCO$$dBDX$$dOCLCF$$dMLY$$dJNE$$dKYC$$dUAP$$dGO3$$dSLV$$dZGR$$dYDX$$dOCLCO$$dBUR$$dIUK$$dVP@$$dISE
000867240 042__ $$apcc
000867240 043__ $$an-us---
000867240 049__ $$aISEA
000867240 05000 $$aRS55.2$$b.E23 2019
000867240 08200 $$a615.1$$223
000867240 1001_ $$aEban, Katherine,$$eauthor.
000867240 24510 $$aBottle of lies :$$bthe inside story of the generic drug boom /$$cKatherine Eban.
000867240 250__ $$aFirst edition.
000867240 264_1 $$aNew York, NY :$$bEcco, an imprint of HarperCollins Publishers,$$c[2019]
000867240 300__ $$axxiv, 482 pages ;$$c24 cm
000867240 336__ $$atext$$btxt$$2rdacontent
000867240 337__ $$aunmediated$$bn$$2rdamedia
000867240 338__ $$avolume$$bnc$$2rdacarrier
000867240 504__ $$aIncludes bibliographical references (pages [421]-461) and index.
000867240 5050_ $$aPart I: Shifting ground. The man who saw further ; The gold rush ; A slum for the rich ; The language of quality ; Red flags -- Part II: India rises. Freedom fighters ; One dollar a day ; A clever way of doing things ; The assignment -- Part III: A cat-and-mouse business. The global cover-up ; Map of the world ; The pharaoh of pharma -- Part IV: Making a case. Out of the shadows ; "Do not give to FDA" ; "How big is the problem?" ; Diamond and ruby ; "You just don't get it" -- Part V: Detectives in the dark. Congress wakes up ; Solving for X ; A test of endurance ; A deep, dark well ; The $600 million jacket -- Part VI: The watershed. The light switch ; We are the champions ; Crashing files ; The ultimate testing laboratory -- Part VII: Reckonings. Flies too numerous to count ; Standing.
000867240 520__ $$a"Many have hailed the widespread use of generic drugs as one of the most important public-health developments of the twenty-first century. Today, almost 90 percent of our pharmaceutical market is comprised of generics, the majority of which are manufactured overseas. We have been reassured by our doctors, our pharmacists and our regulators that generic drugs are identical to their brand-name counterparts, just less expensive. But is this really true? Katherine Eban's Bottle of Lies exposes the deceit behind generic-drug manufacturing--and the attendant risks for global health. Drawing on exclusive accounts from whistleblowers and regulators, as well as thousands of pages of confidential FDA documents, Eban reveals an industry where fraud is rampant, companies routinely falsify data, and executives circumvent almost every principle of safe manufacturing to minimize cost and maximize profit, confident in their ability to fool inspectors. Meanwhile, patients unwittingly consume medicine with unpredictable and dangerous effects. The story of generic drugs is truly global. It connects middle America to China, India, sub-Saharan Africa and Brazil, and represents the ultimate litmus test of globalization: what are the risks of moving drug manufacturing offshore, and are they worth the savings?" -- Dust jacket.
000867240 650_0 $$aGeneric drugs$$xQuality control.
000867240 650_0 $$aDrug adulteration.
000867240 650_0 $$aPharmaceutical industry$$xCorrupt practices$$zUnited States.
000867240 85200 $$bgen$$hRS55.2$$i.E23$$i2019
000867240 909CO $$ooai:library.usi.edu:867240$$pGLOBAL_SET
000867240 980__ $$aBIB
000867240 980__ $$aBOOK